Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 5, 2013, Pages 576-580

  Eldefrawy, Ahmed ^a   Katkoori, Devendar ^a   Abramowitz, Matthew ^a   Soloway, Mark S ^a   Manoharan, Murugesan ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Active surveillance; Cost analysis; Low risk prostate cancer; Markov model; Radiation therapy; Radical prostatectomy

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN;

ANESTHESIA; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; BRACHYTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CLEARANCE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONSULTATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISPOSABLE EQUIPMENT; EVALUATION AND FOLLOW UP; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HEALTH CARE COST; HIDDEN MARKOV MODEL; HISTOPATHOLOGY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; MALE; MEDICAL FEE; MEDICARE; OPERATING ROOM; PHYSICIAN; POSTANESTHESIA CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; REIMBURSEMENT; ROBOTICS; SEPSIS; SIMULATION; TRANSFUSION; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; HUMANS; INPATIENTS; LENGTH OF STAY; MALE; MARKOV CHAINS; MEDICARE; PHYSICIANS; POPULATION SURVEILLANCE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; RISK FACTORS; UNITED STATES;

EID: 84879464726     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.04.005     Document Type: Article

References (27)

1. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Klotz L. What is the best approach for screen-detected low volume cancers?-The case for observation. Urol Oncol 2008, 26:495-499.
3. Bianco F.J., Scardino P.T., Eastham J.A. Radical prostatectomy: Long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology 2005, 66:83-94.
4. Binder J., Kramer W. Robotically-assisted laparoscopic radical prostatectomy. BJU Int 2001, 87:408-410.
5. Lebeau T., Roupret M., Ferhi K., et al. Assessing the complications of laparoscopic robot-assisted surgery: The case of radical prostatectomy. Surg Endosc 2011, 25:536-542.
6. Xylinas E., Ploussard G., Durand X., et al. Robot-assisted extraperitoneal laparoscopic radical prostatectomy: A review of the current literature. Urol Oncol 2010 Sep 21, [Epub ahead of print].
7. Khatlani K., Sharma S., Mendoza P.J., et al. The current state of robot assisted radical prostatectomy. Minerva Urol Nefrol 2010, 62:193-201.
8. Lim T.S., Cheung P.C., Loblaw D.A., et al. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: Acute toxicity results. Int J Radiat Oncol Biol Phys 2008, 72:85-92.
9. Giberti C., Chiono L., Gallo F., et al. Radical retropubic prostatectomy vs. brachytherapy for low-risk prostatic cancer: A prospective study. World J Urol 2009, 27:607-612.
10. Zietman A. Active surveillance: A safe, low-cost prognostic test for prostate cancer. BJU Int 2008, 101:1059-1060.
11. Soloway M.S., Soloway C.T., Eldefrawy A., et al. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 2010, 58:831-835.
12. Eggener S.E., Mueller A., Berglund R.K., et al. A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol 2009, 181:1635-1641. Discussion 41.
13. Hayes J.H., Ollendorf D.A., Pearson S.D., et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: A decision analysis. JAMA 2011, 304:2373-2380.
14. Polinski J.M., Kesselheim A.S. Where cost, medical necessity, and morality meet: Should US government insurance programs pay for erectile dysfunction drugs?. Clin Pharmacol Ther 2011, 89:17-29.
15. Rocco B., Matei D.V., Melegari S., et al. Robotic vs. open prostatectomy in a laparoscopically naive center: A matched-pair analysis. BJU Int 2009, 104:991-995.
16. Bodenheimer T. High and rising health care costs. Part 1: Seeking an explanation. Ann Intern Med 2005, 142:847-854.
17. Bodenheimer T. High and rising health care costs. Part 2: Technologic innovation. Ann Intern Med 2005, 142:932-937.
18. Penson D.F., Chan J.M. Prostate cancer. J Urol 2007, 177:2020-2029.
19. Scales C.D., Jones P.J., Eisenstein E.L., et al. Local cost structures and the economics of robot assisted radical prostatectomy. J Urol 2005, 174:2323-2329.
20. Finkelstein J., Eckersberger E., Sadri H., et al. Open vs. laparoscopic vs. robot-assisted laparoscopic prostatectomy: The European and US Experience. Rev Urol 2010, 12:35-43.
21. Markman M., Luce R. Impact of the cost of cancer treatment: An internet-based survey. J Oncol Pract 2010, 6:69-73.
22. Latorzeff I., Mazurier J., Boutry C., et al. Benefit of intensity modulated and image-guided radiotherapy in prostate cancer. Cancer Radiother 2010, 14:479-487.
23. Parker W.R., Montgomery J.S., Wood D.P. Quality of life outcomes following treatment for localized prostate cancer: Is there a clear winner?. Curr Opin Urol 2009, 19:303-308.
24. Pollack A., Hanlon A.L., Horwitz E.M., et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 2006, 64:518-526.
25. King C.R., Brooks J.D., Gill H., et al. Stereotactic body radiotherapy for localized prostate cancer: Interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 2009, 73:1043-1048.
26. Vigneri P., Herati A.S., Potters L. The second decade of prostate brachytherapy: Evidence and cost based outcomes. Urol Oncol 2010, 28:86-90.
27. Hohwu L., Akre O., Pedersen K.V., et al. Open retropubic prostatectomy vs. robot-assisted laparoscopic prostatectomy: A comparison of length of sick leave. Scand J Urol Nephrol 2009, 43:259-264.